Table 1.
Key characteristics of the study participants.
| S. No. | Age; sex | Concomitant disorder | Baseline respiratory symptoms | Baseline total WBC count (count × 109/L) | Baseline CRP (mg/L) | Aspirated pleural fluid glucose (mmol/L) | Aspirated pleural fluid WBC count (cells/μL) | Neutrophil percentage in the pleural fluid (%) | Number of loculations as detected in USG | Number of loculations as detected in CT |
|---|---|---|---|---|---|---|---|---|---|---|
| 1 | 41; M | None | F, P, D | 11 | 305 | Not available | 790 | 82 | 2 | 3 |
| 2 | 54; M | Dyslipidemia | F, P, C, S | 8 | 161 | 6.9 | 7890 | 70 | 1 | 2 |
| 3 | 33; M | None | P, C, S | 16 | 241 | 6.8 | 1420 | 30 | 1 | 1 |
| 4 | 37; M | COVID-19 | F, P, D | 15 | 160 | Not available | 2100 | 50 | 1 | Not done |
| 5 | 37; M | None | F, P | 14 | Not available | 2.6 | 8740 | 79 | 1 | 1 |
| 6 | 34; M | None | F, P, D | 24 | 191 | 0.2 | 1306 | NA | 1 | 2 |
| 7 | 49; M | Diabetes | P | 13 | 160 | 7.3 | 830 | 87 | 1 | Not done |
| 8 | 72; M | Liver transplantation and CVA | C, S, D | 12 | Not available | Not available | 1610 | 80 | 1 | 2 |
| 9 | 40; Fe | None | F, P, D | 13 | Not available | 1.1 | 21780 | 84 | 1 | 1 |
| 10 | 41; M | G6PD deficiency | F, P, D | 11 | 180 | 0.2 | 2180 | 83 | 1 | 1 |
| 11 | 56; M | G6PD deficiency, diabetes | F, P, C, S, D | 8.8 | 291 | 3.9 | 890 | 89 | 2 | 3 |
| 12 | 48; M | Diabetes, systemic hypertension | P, C, D | 13.3 | 202 | 13.1 | 1580 | 65 | 1 | 2 |
| 13 | 68; M | Diabetes, IHD, atrial fibrillation | D | 14 | 206 | 7.7 | 2160 | 88 | 1 | 1 |
| 14 | 71; M | Dyslipidemia, CVA | F, P, C, S, D | 10 | Not available | 0.2 | 7210 | 90 | 1 | 1 |
| 15 | 64; M | None | D | 16 | Not available | 2.2 | 520 | 61 | 2 | 3 |
M: male; Fe: female; COVID-19: coronavirus 2019 infection; CVA: cerebrovascular accident; IHD: ischemic heart disease; F: fever; P: chest pain; C: cough; D: dyspnea; USG: ultrasonogram; CT: computed tomography.